替奈普酶对比阿替普酶在基底动脉闭塞取栓中首过再灌注的作用
该多中心回顾性队列纳入163例基底动脉闭塞患者,比较静脉替奈普酶(TNK)与阿替普酶(TPA)对首过效应(FPE)的影响。结果显示TNK组FPE发生率更高(51.7% vs 32.9%,p=0.029),且TNK独立关联更高FPE和改良FPE几率,FPE/mFPE均独立关联90天良好功能结局,但TNK与功能结局无独立关联。
要点
- 基底动脉闭塞取栓前使用TNK较TPA提高首过再灌注(FPE)几率(aOR 2.37)。
- FPE和改良FPE均独立预测90天步行独立结局(aOR 2.94和5.11)。
- TNK未显示与90天功能结局的独立关联,再灌注优势未直接转化为临床获益。
核心结论
- 在基底动脉闭塞队列中,静脉TNK较TPA增加首过再灌注(FPE)的几率,FPE强烈预测功能恢复,但TNK与90天功能结局无独立关联。
研究设计与样本
- 多中心回顾性队列分析美国14个卒中系统2020年1月至2024年8月连续163例基底动脉闭塞患者,最终分析133例。
- 纳入发病4.5小时内接受静脉TNK或TPA者,排除早期再灌注27例和手术中止3例。
主要发现
- FPE(eTICI 2c-3)发生于55/133例(41.4%),TNK组51.7%高于TPA组32.9%(p=0.029)。
- TNK独立关联更高FPE几率(aOR 2.37,95%CI 1.13-4.98,p=0.023)和改良FPE几率(aOR 2.74,95%CI 1.20-6.25,p=0.017)。
- FPE独立关联90天mRS 0-3(aOR 2.94,95%CI 1.18-7.33,p=0.021),mFPE关联更强(aOR 5.11,95%CI 1.81-14.43,p=0.002)。
- TNK与TPA相比未显示与功能结局的独立关联。
临床怎么用
- 基底动脉闭塞取栓前选择静脉溶栓药物时,TNK可能提高首过再灌注机会,但需注意其未直接证明改善功能结局。
局限性
- 回顾性设计、样本量有限(最终分析133例),可能存在选择偏倚和未测量混杂。
- TNK与功能结局无独立关联,再灌注优势的临床获益未直接证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The first-pass effect (FPE), defined as excellent reperfusion after a single attempt, is associated with improved outcomes in large vessel occlusion stroke. We evaluated whether intravenous tenecteplase (TNK) compared with alteplase (TPA) increases the likelihood of FPE in basilar artery occlusion (BAO). METHODS: We analyzed 163 consecutive BAO patients treated with intravenous TNK or TPA within 4.5 h of last known well across 14 U.S. stroke systems (January 2020-August 2024). Patients with early reperfusion (n = 27) or aborted procedures (n = 3) were excluded. Multivariable ordinal and logistic regression identified predictors of FPE (expanded Thrombolysis in Cerebral Infarction [eTICI] 2c-3) and modified FPE (mFPE, eTICI 2b-3), and FPE/mFPE association with 90-day outcomes (modified Rankin Scale [mRS] 0-3). RESULTS: FPE occurred in 55 of 133 patients (41.4%) and was more frequent with TNK than TPA (51.7% vs 32.9%, p = 0.029). TNK was independently associated with higher odds of FPE (adjusted odds ratio [aOR] 2.37, 95% confidence interval [CI] 1.13-4.98, p = 0.023) and mFPE (aOR 2.74, 95% CI 1.20-6.25, p = 0.017). Both FPE and mFPE were independently associated with ambulatory outcomes at 90-days (FPE: aOR 2.94, 95% CI 1.18-7.33, p = 0.021; mFPE: aOR 5.11, 95% CI 1.81-14.43, p = 0.002). TNK compared with TPA did not show an independent association with functional outcome. INTERPRETATION: In this multicenter BAO cohort, TNK increased the odds of achieving FPE compared with TPA. As FPE strongly predicted functional recovery, these findings suggest TNK may confer a reperfusion advantage with potential clinical benefit, although a direct outcome effect was not demonstrated. ANN NEUROL 2026;99:692-704.
引用
- Wolman DN, Karamchandani RR, Hemmer S, et al. Tenecteplase Versus Alteplase for First-Pass Reperfusion in Basilar Artery Occlusion Stroke Thrombectomy. Ann Neurol. 2025. PMID: 41288159. doi:10.1002/ana.78102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。